THE BLOG
Honest pricing dispatches.
Short, reported pieces on what's actually happening in the US prescription cash market.
Insulin
Insulin without insurance in 2026: what cash prices actually look like
After the federal $35 cap and biosimilar wave, insulin pricing is no longer one number. Here's the real range.
May 12, 2026 · 6 min read
GLP-1
What Ozempic, Wegovy, and Mounjaro really cost without insurance
Compounded vs branded vs Eli Lilly Direct — the GLP-1 cash market in 2026.
May 5, 2026 · 8 min read
ADHD
The ADHD stimulant shortage isn't over — here's how to navigate it
Adderall and Vyvanse remain spotty across chain pharmacies. Independent and warehouse pharmacies often have better stock.
Apr 28, 2026 · 5 min read
Generics
Generic drugs 101: what FDA equivalence actually guarantees
If a generic is FDA AB-rated, it's pharmaceutically and therapeutically equivalent to the brand. Period.
Apr 20, 2026 · 4 min read
Behind the scenes
How Tuesdays verifies every price (and what we won't show you)
Our scraper. Our rules. Why we sometimes show 'no verified price' instead of guessing.
Apr 12, 2026 · 5 min read
Founder
Why I built Tuesdays, a note from founder Naufil Shah Daud
Naufil Shah Daud, the founder of Tuesdays, on why prescription pricing is broken in America and why he funds Tuesdays out of his own pocket.
May 14, 2026 · 7 min read